Quote:“We needed 60 votes in the Senate; we got 60. We needed 218 votes in the House; we got 219,” said Ron Pollack, executive director of Families USA, a health care advocacy group and ally of the White House that worked to corral industry support for the bill. “Had structural changes to pharmaceutical pricing been in the bill, the Affordable Care Act would not have been enacted.”
PhRMA coughed up about $32 billion to help close a large gap in Medicare drug coverage known as the “doughnut hole” — which meant that once seniors got about $2,800 in drug coverage, they were on the hook for all the costs until they hit $6,400, when coverage kicked in again. The trade group also agreed to pay tens of billions in taxes and to increase drug discounts in Medicaid to help with the broader financing of the law.
The drug industry won two other victories as the law took shape that weren’t part of its initial deal with Democrats. And both are constraining policymakers today.
One involved a new quasi-government entity — the Patient Centered Outcomes Research Institute, known as PCORI. It was set up by the Affordable Care Act to test how different medical treatments stack up against one another — but PhRMA insisted that PCORI would not be able to take cost effectiveness into account — and it doesn't.
The Tea Party uprising against Obamacare in the summer of 2009 — and the outlandish claims that it would set up “death panels” — fed into PhRMA’s arguments. Politicians didn’t want to do anything that could fuel fears that the health bill, already controversial enough, would limit Americans’ access to treatment.
Critics say that restriction has hamstrung the independent expert group, making it hesitant to take on politically sensitive issues and unable to assess the true value of treatments. A Center for American Progress report in May found its “potential impact on the nation's health care system has not been fully realized” — which is exactly what PhRMA sought, to protect its turf.
Perhaps more significantly, the drugmakers won an unprecedented, guaranteed 12-year monopoly for biologic drugs — a costly class of new cell-based therapies that are more complicated to manufacture than more familiar chemical drugs.
Twelve years — as opposed to five that most other drugs get — means biologics get a much longer time to dictate prices on the market before they have to face generic-like completion.
The dozen-year market lock is still stirring controversy. One of PhRMA’s top demands for the 12-country Trans Pacific Partnership negotiations was that the monopoly be extended internationally, but other countries balked. The TPP deal set the target at eight years, and the drug industry’s ire is one shadow hanging over the sweeping, unfinished accord.
But the Obama administration’s repeated bid to cut the domestic market protections to seven years – what it had sought during the Obamacare negotiations — has gained no traction on the Hill.
Seven years later, Tauzin’s goal is intact. PhRMA’s not the meal; and everyone else is still picking up that tab.
So now you don't know how voting majorities work or work
Top 10 Most Recent News Articles
Avelo Tests Loyalty Math With WeSalute Fare Discounts
Airline discounts can look like generosity until the load factor starts talking back. Avelo Airlines has joined WeSalute with fare discounts for active-duty military members, veterans, first responders, nurses, medical professionals, public servants, teachers and eligible family members. It is a sensible move for a young carrier built around smaller airports and lower...
Continue Reading
Autoliv's Omni Safety Award Is a Promising Early Signal
Reclined car seats are becoming a real engineering headache, not some showroom gimmick, and Autoliv has put a marker down with Omni Safety™. The company received 2026 Automotive News PACE Pilot recognition for the system, which tackles occupant protection when people are sitting farther back than conventional vehicle safety designs assumed. That matters because...
Continue Reading
Cambrian Turns Dairy Wastewater Into Long-Term Gas
A Wisconsin dairy plant just traded lagoon duty for a 20-year service arrangement, and that is more consequential than the usual shiny renewable-gas headline. Cambrian Innovation says it has commissioned and is operating a wastewater treatment and resource recovery system that handles roughly 280,000 gallons a day. That works out to about 102 million gallons annually, a...
Continue Reading
Trilith Holiday Tour Blends Film Access and Giving
Snow machines, trolley rides, and a mental-health subsidy are sharing the same stage in Fayetteville this holiday season. That is an unusual mix, but it fits Trilith Foundation’s stated mission better than another generic lights-and-cocoa event ever could. From Nov. 21 through Dec. 31, the Foundation is turning its guided Trilith Studios tour into a seasonal experience...
Continue Reading
LG Channels UAE Push Tests the Free Streaming Model
A television's idle screen is turning into contested real estate in the UAE. LG Channels is adding programming from Rakuten TV, Stingray and Red Bull TV to its free, ad-supported service, and that matters for more than somebody hunting a movie after dinner. This is a practical push to make webOS-powered screens more useful, more frequently used and, eventually, more...
Continue Reading
TYYY Liquidation Leaves Holders With a Tight Exit Window
A fund can vanish faster than investors can read the fine print, and TYYY is doing exactly that. Exchange Traded Concepts has approved the closure and liquidation of the xETFs TSLA Daily Income ETF, with the fund expected to cease operations and distribute cash on or about November 20, 2026. This is not a debate about whether holders should love or hate Tesla. The product...
Continue Reading
Leqembi’s Real-World Data Gives BioArctic More Weight
A Harder Look at Treatment Staying Power Alzheimer’s drug data rarely arrive without a thicket of caveats, and that is exactly why this Leqembi update deserves a calm read rather than a victory lap. BioArctic’s partner Eisai presented a three-year real-world analysis at CTAD 2026 covering 560 early Alzheimer’s patients across 13 U.S. sites. The headline is striking:...
Continue Reading
ELEGOO's Formnext Push Tests a Broader 3D Ambition
Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...
Continue Reading
Wealth Forum Puts AI and Tokenisation Before Private Wealth
Private wealth is about to get squeezed from three directions at once: younger heirs, smarter machines and assets that do not fit neatly in the old family-office binder. That is the real backdrop to the Future of Wealth Forum, a new GFTN and Luxembourg House of Financial Technology partnership slated for Luxembourg City on September 27-29, 2027. It is early days,...
Continue Reading
CD Rates Offer Stillness as Stocks and Gold Wobble
November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...
Continue ReadingTop 5 Most Recently Viewed Articles
Embracing Harmony and Cooperation in Today's World
Understanding the Essence of Hehe Culture The concept of "Hehe" in Chinese culture symbolizes harmony, peace, and cooperation, deeply embedded in the collective mindset. This philosophy, with roots extending over thousands of years, emphasizes living in balance not only with one another but also with nature and oneself. The teachings of Hehe are particularly significant...
Continue Reading
Current Trends in Mortgage Rates and Home Buying Activity
The average rate for a 30-year fixed-rate mortgage dropped to 6.08% in 2024, hitting its lowest point in two years. This slight decrease from 6.09% the previous week caught the eye of potential home buyers and homeowners considering refinancing. In contrast, the average rate for a 15-year mortgage ticked up by a single basis point to reach 5.16%. These small fluctuations...
Continue Reading
Mueller Water Products Engages at 2024 Baird Industrial Conference
Mueller Water Products to Engage in the Baird Industrial Conference Mueller Water Products, Inc. (NYSE: MWA), headquartered in Atlanta, is set to participate in the Baird 2024 Global Industrial Conference. This prestigious event will take place in a vibrant city known for its industrial drive and innovation. Mueller’s management team is looking forward to sharing...
Continue Reading
SANY Showcases Advanced Eco-Friendly Solutions at bauma
SANY Showcases Advanced Eco-Friendly Solutions at bauma The 34th bauma, recognized as the world's leading trade fair for construction machinery, recently wrapped up in Munich. This year's theme was "The World of Efficiency, Your Partner to Create the Best", and SANY Group, in collaboration with Putzmeister, put forth an impressive display of cutting-edge technology and...
Continue Reading
Orbit International Corp Completes $1 Million Power Supply Order
Orbit International Corp Secures Major Follow-On Order Orbit International Corp. (OTCID Basic Market: ORBT), a prominent player in electronic manufacturing and software solutions, has announced the receipt of a new order valued at approximately $1,000,000. This order, secured by its Orbit Power Group (OPG), pertains to a commercial power supply that is utilized in...
Continue Reading